France· FR:61328727
NILEMDO 180 mg, comprimé pelliculé
A medicinal product containing acide bempédoïque, registered in France by DAIICHI SANKYO EUROPE (ALLEMAGNE), on the national reimbursement list.
Checked against Base de données publique des médicaments — BDPM (France) on
Informational only — not a medical device.
The record
At a glance
Base de données publique des médicaments — BDPM (France)- Active substance
- ACIDE BEMPÉDOÏQUE
- Manufacturer
- DAIICHI SANKYO EUROPE (ALLEMAGNE)
- Country
- France (FR)
- ATC code
- —
- Reimbursed
- Yes
- Source register
- Base de données publique des médicaments — BDPM (France)
- Last checked
- September 12, 2026
Packs & prices · 1
1 priced- cip133400930279021plaquette(s) thermosoudée(s) PVC aluminium de 30 comprimé(s)EUR 57.27
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Acide bempédoïque in 15 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- CzechiaNILEMDODaiichi Sankyo Europe GmbH, Mnichov
- SwitzerlandNilemdo 180 mg, FilmtablettenDaiichi Sankyo (Schweiz) AG
- BelgiumNilemdo 180 mgDaiichi Sankyo Europe
- IrelandNilemdo 180 mg film-coated tabletsDaiichi Sankyo Europe GmbH
- United StatesNexletolEsperion Therapeutics, Inc.
- SwedenNilemdo 180 mg Filmdragerad tablettDaiichi Sankyo Europe GmbH
- IcelandNilemdoDAIICHI SANKYO EUROPE GmbH*
- NetherlandsNilemdo 180 mg, filmomhulde tablettenDAIICHI SANKYO EUROPE GmbH
Authorised across Europe · EMA
The same active substance is authorised in 3 EEA countries. Names it is sold under:
- Iceland · Nilemdo
- Liechtenstein · Nilemdo
- Norway · Nilemdo
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Base de données publique des médicaments — BDPM (France). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/fde14355-ca24-4ed7-a220-0f66f2ede73e GET /v1/drugs/fde14355-ca24-4ed7-a220-0f66f2ede73e?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"cis": "61328727",
"date_amm": "2020-04-01",
"type_amm": "Procédure centralisée",
"numero_ue": "EU/1/20/1425",
"substance": "ACIDE BEMPÉDOÏQUE",
"statut_amm": "Autorisation active",
"statut_bdm": null,
"forme_pharmaceutique": "comprimé pelliculé",
"voies_administration": "orale",
"etat_commercialisation": "Commercialisée",
"surveillance_renforcee": "Non"
}See everything about acide bempédoïque.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.